Life Sciences Tools and Services
Company Overview of Lonza Biologics PLC
Lonza Biologics PLC operates as a contract manufacturer of monoclonal antibodies and recombinant proteins. It engages in protein engineering, viral testing, toxicology studies, and clinical trials. The company was formerly known as Celltech Biologics PLC. As a result of acquisition of Celltech Biologics PLC by Lonza Group AG, Celltech Biologics PLC's name was changed to Lonza Biologics PLC in July 1996. The company was incorporated in 1992 and is based in Slough, United Kingdom. Lonza Biologics PLC operates as a subsidiary of Lonza Group AG.
228 Bath Road
Slough, SL1 4DX
Founded in 1992
44 1753 777 000
44 1753 777 001
Key Executives for Lonza Biologics PLC
Similar Private Companies By Industry
|14M Genomics Ltd||Europe|
|Ablatus Therapeutics Limited||Europe|
|Accuro Biologics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Lonza Biologics PLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.